JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Right arrow Help viewing high resolution images
Right arrow Return to article
Click on image to view larger version.


Figure 6


FIGURE 6.  Biodistribution of FROP-1 in female BALB/c nu/nu mice carrying FRO82-2 tumors (n = 3 animals per time point) (A) or MCF-7 tumors (n = 6 animals per time point) (B). Animals received intravenous injection of 131I-FROP-1, and radioactivity was measured in tumor and control organs after 5, 15, 45, and 135 min. SEM is shown. (C) Tumor-to-muscle ratios calculated for FRO82-2 and MCF-7 tumors at various time points. (D) Biodistribution of 125I-FROP-1 at 45 min comparing FRO82-2 and MCF-7 tumors incubated with and without Matrigel (BD Biosciences) (n = 3 animals per time point).





Right arrow Return to article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE